Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
2017 · Nature Communications · 173 citations
https://doi.org/10.1038/s41467-017-01385-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
100
Papers
584
Citations
11
h-index
11
i10-index
Dongling Gao is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Virus-based gene therapy research & Cancer Research and Treatments & Immunotherapy and Immune Responses. The author has an h-index of 11, co-authored 85 publications.
https://doi.org/10.1038/s41467-017-01385-8
https://doi.org/10.1038/s41467-024-53164-x
https://doi.org/10.1186/s12864-025-11393-4
Click to start Chat